Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elanco Animal Health Incorporated Common Stock vs Enovix Corporation — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.5 (market cap $11.17B), while Enovix Corporation trades at $2.51 (market cap $561.79M). The key difference: Elanco Animal Health Incorporated Common Stock is far larger — about 19.9× Enovix Corporation's market cap, and Elanco Animal Health Incorporated Common Stock is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and Enovix Corporation for 11 Days on average.
| ELAN | ENVX | |
|---|---|---|
Market Cap | $11.17B | $561.79M |
Volume | 4,196,242 | 5,898,906 |
Sector | Health | Industrials |
52-Week High | $26.84 | $13.19 |
52-Week Low | $19.76 | $2.50 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $14.56B | $623.49M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVX trades at $2.55, down 5.56% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with negative moving averages and oscillators. Fundamentally, the company continues to burn cash with a net income margin of -473.89% in 2026, though revenue growth remains positive at 32% year-over-year. Recent CEO transition and strategic focus on defense battery manufacturing create uncertainty about execution.
The outlook remains challenging with significant cash burn and negative profitability, though analyst consensus is bullish with a $10.75 price target representing 321% upside. Key risks include execution challenges, high cash consumption, and competitive pressures in the battery sector. The company's $552 million cash position provides runway but requires successful commercialization to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Elanco Animal Health Incorporated Common Stock
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
